Novartis | Koszty Operacyjne



Operating Expenses Zmiana Data
AbbVie USD 9.61B 6.98B 2025-03
Amgen USD 6.78B 401M 2024-12
AstraZeneca USD 9.91B 2.94B 2025-03
Bausch Health Companies USD 1.98B 32M 2025-03
Biogen USD 2.01B 13.3M 2024-12
Bristol-Myers Squibb USD 8.23B 3.32B 2025-03
Canopy Growth CAD 98.58M 10.03M 2024-12
Corcept Therapeutics USD 156.63M 20.68M 2024-12
Drreddys Laboratories INR 64.87B 2.26B 2024-12
Eli Lilly USD 7.32B 1.06B 2025-03
Gilead Sciences USD 4.43B 687M 2025-03
GlaxoSmithKline GBP 5.3B 2.12B 2025-03
Glaxosmithkline GBP 7.42B 408M 2024-12
Indivior 200M 193M 2025-03
J&J USD 8.26B 10.37B 2025-03
Merck USD 9.66B 1.67B 2025-03
Novartis USD 11.28B 1.73B 2024-12
Novartis USD 10.15B 579M 2024-12
Pacira USD 162.55M 145.55M 2024-12
Perrigo USD 1.03B 13.4M 2024-12
Pfizer USD 10.05B 8.12B 2025-03
Prestige Brands USD 198.36M 1.09M 2024-12
Roche Holding CHF 11.43B 1.48B 2024-12
Sanofi EUR 8.32B 1.55B 2025-03
Sanofi EUR 6.77B 3.75B 2024-12
Supernus Pharmaceuticals USD 152.75M 17.91M 2024-12
Zoetis USD 1.59B 71M 2024-12



Novartis Koszty Operacyjne - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.